Bilimsel çalışmalar
Doç. Dr. Kadriye Bir Yücel
67 yayın. Her yayının yanında bilginin kaynağı yazar.
-
Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group
The Oncologist, 2023
DOI 10.1093/oncolo/oyad257 PMID 37676712 8 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex
-
443P Efficacy and safety of CDK 4/6 inhibitors in patients with bone marrow-involved metastatic breast cancer
Annals of Oncology, 2023
DOI 10.1016/j.annonc.2023.09.619 Açık erişimli tam metinKaynak: OpenAlex
-
Nivolumab-ipilimumab combination therapy-induced seronegative encephalitis; rapid response to steroid plus intravenous immunoglobulin (IVIG) treatment
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2023
DOI 10.1177/10781552221118529 PMID 35938177 5 atıf (Europe PMC) Kaynak: Europe PMC
-
Survival Outcomes of Non-squamous Cell Carcinoma and Rare Squamous Cell Carcinoma Variants of the Larynx
Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 2023
DOI 10.1007/s12070-023-03934-8 PMID 37974887 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: Europe PMC
-
Retrospective Analysis of Real-Life Data Evaluating the Optimal Time Between Gastrectomy and Adjuvant Chemotherapy in Resected Gastric Cancer
Journal of gastrointestinal cancer, 2023
DOI 10.1007/s12029-023-00916-5 PMID 36821038 1 atıf (Europe PMC) Kaynak: Europe PMC
-
Effects of Sarcopenia, Myosteatosis, and the Prognostic Nutritional Index on Survival in Stage 2 and 3 Gastric Cancer Patients
Nutrition and cancer, 2023
DOI 10.1080/01635581.2022.2121845 PMID 36093734 7 atıf (Europe PMC) Kaynak: Europe PMC
-
Greater financial toxicity correlates with increased psychological distress and lower quality of life among Turkish cancer patients
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2023
DOI 10.1007/s00520-023-07586-w PMID 36700998 22 atıf (Europe PMC) Kaynak: Europe PMC
-
2066P Evaluation of the quality and reliability of ChatGPT and Perplexity's responses about rectal cancer
Annals of Oncology, 2023
DOI 10.1016/j.annonc.2023.09.848 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex
-
Prognostic Significance of the Gustave-Roussy Immune Score in Colon Cancer Patients Treated with Adjuvant CAPEOX Regimen
Eurasian Journal of Medical Investigation, 2023
DOI 10.14744/ejmi.2023.93298 Açık erişimli tam metinKaynak: OpenAlex
-
429P The impact of HER2 status on the efficacy of CDK 4/6 inhibitors: A multicenter study
Annals of Oncology, 2023
DOI 10.1016/j.annonc.2023.09.605 Açık erişimli tam metinKaynak: OpenAlex
-
2162P Can artificial intelligence provide accurate and reliable answers to cancer patients' questions? Comparison of chatbots based on the ESMO Patient Guide about cancer pain
Annals of Oncology, 2023
DOI 10.1016/j.annonc.2023.09.944 Açık erişimli tam metinKaynak: OpenAlex
-
The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors
Scientific Reports, 2022
DOI 10.1038/s41598-022-20056-3 PMID 36192500 15 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID
-
ROAR trial: which treatment is effective after progression?
The Lancet Oncology, 2022
DOI 10.1016/s1470-2045(21)00754-3 PMID 35240094 Kaynak: OpenAlex
-
Neutrophil–lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study)
Journal of Oncology Pharmacy Practice, 2020
DOI 10.1177/1078155219900908 PMID 32054412 9 atıf (Europe PMC) Kaynak: OpenAlex
-
Akciğer Kanserinde Paraneoplastik Sendromlar
2020
Kaynak: OpenAlex
-
The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer
Journal of Oncology Pharmacy Practice, 2019
DOI 10.1177/1078155219883004 PMID 31653193 17 atıf (Europe PMC) Kaynak: OpenAlex
-
EP1034 Comparing the efficiency of interval debulking surgery after neoadjuvant chemotherapy with primary debulking surgery in patients with stage 3 and 4 ovarian carcinoma: multicenter real world data
International Journal of Gynecological Cancer, 2019
DOI 10.1136/ijgc-2019-esgo.1078 Açık erişimli tam metinKaynak: OpenAlex